Snapshot

The EMA Marketing Authorisation under Exceptional Circumstances pathway has been developed by the European Medicines Agency of EU-EMA.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Regional regulatory initiatives can help optimize the efficient use of an agency’s resources. The following countries participate in this initiative/pathway: EU-EMA

Info not found